Your session is about to expire
← Back to Search
Vision Therapy for Lazy Eye
N/A
Recruiting
Led By Jingyun Wang
Research Sponsored by State University of New York College of Optometry
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Children with best-corrected visual acuity (BCVA) of 20/40 (equivalent to 0.3 logMAR) or worse in the amblyopic eye (ranging from 20/40 to 20/400), and interocular difference of BCVA was at least two logMAR lines
Combined type included those who meet the criteria of both anisometropia and strabismus
Must not have
Born before 32 weeks gestational age
Congenital or acquired macular pathology
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 weeks
Awards & highlights
No Placebo-Only Group
Summary
This trial investigates how patching and foveation therapy can improve vision in children with amblyopia. Patching involves covering the stronger eye to strengthen the weaker one. Foveation therapy helps the weaker eye focus better. The goal is to see if these treatments can enhance visual clarity and coordination.
Who is the study for?
This trial is for children aged 4-16 with 'lazy eye' due to refractive issues like anisometropia, strabismus, or both. They must have a certain level of reduced vision in the affected eye and not have been born prematurely or have neurological conditions that could affect their eyes.
What is being tested?
The study tests how well different treatments work for lazy eye in kids. Some will use an eye patch while others will try visual exercises like After-image and MIT trainer to improve their vision and how they fixate on objects.
What are the potential side effects?
Wearing an eye patch might cause discomfort or skin irritation around the patched area. Visual exercises may lead to eyestrain, headaches, or temporary dizziness but typically don't cause serious side effects.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
My child's weaker eye sees worse than 20/40 and has a significant difference compared to the better eye.
Select...
I have both uneven eye prescription and misaligned eyes.
Select...
I am between 8-16 years old with strabismic amblyopia, prescribed foveation therapies.
Select...
My lazy eye is due to a difference in vision or eye alignment.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I was born prematurely, before 32 weeks of pregnancy.
Select...
I have a condition affecting the central part of my retina.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 12 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 weeks
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
OCT eccentric fixation
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Group I: foveation therapyExperimental Treatment1 Intervention
After-image foveation therapy training is 10 mins; MIT training is 5 minutes.
Group II: Patching groupExperimental Treatment1 Intervention
part-time patching following PEDIG guidelines.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
eye patch
2016
N/A
~80
Research Highlights
Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
The most common treatments for Lazy Eye (Amblyopia) include patching the stronger eye, atropine drops, and vision therapy. Patching forces the weaker eye to work harder, thereby improving its visual acuity and alignment.
Atropine drops blur vision in the stronger eye, similarly encouraging use of the weaker eye. Vision therapy involves exercises that enhance eye coordination and focus.
Optical Coherence Tomography (OCT) is used to measure eccentric fixation, fixation eye movement, and macular sensitivity, providing detailed insights into the structural and functional improvements in the amblyopic eye. These treatments are crucial as they help in the development of normal vision by promoting the use of the weaker eye, thereby preventing long-term visual impairment.
Relating optical coherence tomography to visual fields in glaucoma: structure-function mapping, limitations and future applications.Adaptive optics optical coherence tomography with dynamic retinal tracking.Temporal variation in diabetic macular edema measured by optical coherence tomography.
Relating optical coherence tomography to visual fields in glaucoma: structure-function mapping, limitations and future applications.Adaptive optics optical coherence tomography with dynamic retinal tracking.Temporal variation in diabetic macular edema measured by optical coherence tomography.
Find a Location
Who is running the clinical trial?
State University of New York College of OptometryLead Sponsor
19 Previous Clinical Trials
1,106 Total Patients Enrolled
Jingyun WangPrincipal InvestigatorSUNY College of Optmetry
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- Your eyes have a big difference in vision prescription between each other.I have strabismus with a deviation of 10 or more, or it's well-aligned after surgery.I am between 4-12 years old and prescribed patching for strabismic amblyopia.I was born prematurely, before 32 weeks of pregnancy.I have a health condition known to affect the eyes.I have a condition affecting the central part of my retina.My child's weaker eye sees worse than 20/40 and has a significant difference compared to the better eye.I have both uneven eye prescription and misaligned eyes.I am between 8-16 years old with strabismic amblyopia, prescribed foveation therapies.My lazy eye is due to a difference in vision or eye alignment.
Research Study Groups:
This trial has the following groups:- Group 1: Patching group
- Group 2: foveation therapy
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.